Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
224
-
Total 13F shares, excl. options
-
59.2M
-
Shares change
-
+867K
-
Total reported value, excl. options
-
$3.78B
-
Value change
-
-$42.9M
-
Put/Call ratio
-
0.58
-
Number of buys
-
106
-
Number of sells
-
-140
-
Price
-
$63.88
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q1 2022
297 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q1 2022.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 224 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59.2M shares
of 62.5M outstanding shares and own 94.71% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.53M shares), BlackRock Inc. (5.38M shares), FMR LLC (5.33M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.93M shares), WELLINGTON MANAGEMENT GROUP LLP (3.91M shares), STATE STREET CORP (2.27M shares), CADIAN CAPITAL MANAGEMENT, LP (1.92M shares), JPMORGAN CHASE & CO (1.68M shares), Casdin Capital, LLC (1.55M shares), and ALLIANCEBERNSTEIN L.P. (1.51M shares).
This table shows the top 224 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.